Haleon plc/£HLN
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Haleon plc
Haleon plc is a consumer healthcare company that focuses on the development, manufacturing, and distribution of health products. The company operates in the healthcare industry, specifically targeting wellness and over-the-counter products. Haleon's portfolio includes well-known brands such as Sensodyne, Advil, and Centrum, which are aimed at providing solutions for oral health, pain relief, and dietary supplementation. Headquartered in the United Kingdom, the company maintains a global presence with a significant geographic footprint in numerous markets. Haleon's strategic positioning lies in its focus on scientifically backed consumer health products and a robust brand portfolio, which supports its competitive presence in the healthcare sector.
Ticker
£HLN
Sector
Primary listing
LSE
Employees
24,535
Headquarters
Website
Haleon plc Metrics
BasicAdvanced
£30bn
18.39
£0.19
0.33
£0.07
2.00%
Price and volume
Market cap
£30bn
Beta
0.33
52-week high
£4.16
52-week low
£3.34
Average daily volume
21m
Dividend rate
£0.07
Financial strength
Current ratio
0.922
Quick ratio
0.677
Long term debt to equity
47.294
Total debt to equity
52.372
Dividend payout ratio (TTM)
36.71%
Interest coverage (TTM)
7.32%
Profitability
EBITDA (TTM)
2,729
Gross margin (TTM)
64.69%
Net profit margin (TTM)
15.11%
Operating margin (TTM)
22.69%
Effective tax rate (TTM)
21.93%
Revenue per employee (TTM)
£450,000
Management effectiveness
Return on assets (TTM)
4.65%
Return on equity (TTM)
10.27%
Valuation
Price to earnings (TTM)
18.389
Price to revenue (TTM)
2.77
Price to book
1.84
Price to tangible book (TTM)
-3.29
Price to free cash flow (TTM)
13.758
Free cash flow yield (TTM)
7.27%
Free cash flow per share (TTM)
0.247
Dividend yield (TTM)
2.00%
Growth
Revenue change (TTM)
-1.81%
Earnings per share change (TTM)
17.83%
3-year revenue growth (CAGR)
0.53%
3-year earnings per share growth (CAGR)
17.25%
3-year dividend per share growth (CAGR)
43.55%
What the Analysts think about Haleon plc
Analyst ratings (Buy, Hold, Sell) for Haleon plc stock.
Haleon plc Financial Performance
Revenues and expenses
Haleon plc Earnings Performance
Company profitability
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Haleon plc stock?
Haleon plc (HLN) has a market cap of £30B as of April 30, 2026.
What is the P/E ratio for Haleon plc stock?
The price to earnings (P/E) ratio for Haleon plc (HLN) stock is 18.39 as of April 30, 2026.
Does Haleon plc stock pay dividends?
Yes, the Haleon plc (HLN) stock pays dividends to shareholders. As of April 30, 2026, the dividend rate is £0.068 and the yield is 2%. Haleon plc has a payout ratio of 36.71% on a trailing twelve-month basis.
When is the next Haleon plc dividend payment date?
The next Haleon plc (HLN) dividend payment is scheduled for May 14, 2026.
What is the beta indicator for Haleon plc?
Haleon plc (HLN) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.